Brisbane Economic Development Agency has partnered with US-based investment facilitator Life Science Nation (LSN) to advance ten (10) local ventures supporting them to launch a global funding campaign and fast track connections with international capital funders and strategic licensing and distributions partners.
Each module will have specific content, real world exercises, and training on how to utilise tools to support the success of a global fund-raising campaign. Participants will also benefit from the expertise of global MedTech giants such as Johnson & Johnson, Medtronic, Phillips, Stryker and local mentorship of Federal & State Government, Advisory, Universities, Research Institutions and other leading MedTech companies and funders.
The accelerator will culminate with the opportunity to pitch to international investors during JP Morgan Health Week in San Francisco USA. The application process is competitive for the ten (10) seats aligned to the cohort for FY2025.
Develop capability in global brand building and learn how to create Investor messaging for funding success. Develop the skills and relationships to access a global alliance network.
Attend a Global Shark Tank for final pitch readiness in preparation for Pitch Forums and Investment Roundtables.
Attend JP Morgan Health week 2025 in San Francisco and participate in the pitch forum and Investor Roundtables (Physical attendance required in San Francisco, USA).
Ongoing support following your participation in the MedTech accelerator program.
"The city has a highly skilled workforce, stable regulatory frameworks, and manufacturing capability. “You don’t find that in many places, and it gives investors comfort. If you’re an innovator with an idea in biotech and MedTech, you couldn’t be in a better place.”
Vaxxas Chief Executive Officer David Hoey.
“Brisbane is a fantastic place to seed and grow MedTech companies, with access to major hospital networks, world class research facilities, top tier university talent and the outstanding lifestyle that Brisbane affords.”
Microba Chief Executive Officer Dr Luke Reid.